Teva Starts The Year With Phase III Data And Growth

 
• By Jessica Merrill
  
schizophrenia
Teva announced positive Phase III data for a long-acting version of olanzapine • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business